In order to solve the technical problem of high-efficiency expression of CLMP
protein in tumors in the prior art, the invention creatively provides a
clostridium butyricum
engineering strain. According to the
engineering bacterial strain, ATCC19398
clostridium butyricum is used as a
chassis bacterial strain, and the
engineering bacterial strain comprises a
recombinant expression vector for expressing CLMP
protein. The inventor accidentally finds that the
clostridium butyricum as a
chassis strain can realize expression of CLMP in
tumor cells, the technical problem of expression reduction of CLMP
protein in
colorectal cancer is fundamentally solved, and the
clostridium butyricum has important significance in treatment of
colorectal cancer. On the basis, the inventor knockout a
purine synthesis
related gene purM in the
clostridium butyricum to realize the enrichment of the
clostridium butyricum in tumors; further, by knocking out the
protease gene lon, the expression quantity of CLMP protein is remarkably increased while precise positioning aiming at the tumor is met, so that the inhibition effect on the tumor is further improved. Moreover, the engineering strain can significantly inhibit the growth of tumors in a mouse model, is good in safety, provides a new idea for the treatment of
colorectal cancer, and has important practical application value.